Gene therapy steadies erratic heartbeat in pigs; potential treatment for human arrhythmias.
Five pigs were treated with a modified adenovirus containing the gene that codes for the inhibitory G protein, a protein that is active in the heart's atrioventricular node and helps control heartbeat. After 1 week, measurements of electrical impulse rates confirmed that the gene was taken up into the pigs' heart cells, with 20% of the treated pigs exhibiting a drop in heart rate compared to a control group given the virus with a gene unrelated to heart function.
According to the researchers, gene therapy for cardiac arrhythmias has the potential for being more specific than current drug therapy--meaning fewer side effects-and also would avoid the risk of infection associated with implanted pacemakers or defibrillators. (Nature Medicine 2000;6:1395-1398.)
|Printer friendly Cite/link Email Feedback|
|Comment:||Gene therapy steadies erratic heartbeat in pigs; potential treatment for human arrhythmias.|
|Article Type:||Brief Article|
|Date:||Dec 15, 2000|
|Previous Article:||Hepatitis virus infection appears to have little impact on survival after heart transplant.|
|Next Article:||Selected gene therapy for head and neck cancer may be feasible.|